PubRank

Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT

Clinical Trial ID NCT01810120

PubWeight™ 4.98‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01810120

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Innate immune recognition. Annu Rev Immunol 2001 26.65
2 Biology of natural killer cells. Adv Immunol 1989 14.77
3 Hematopoietic stem-cell transplantation. N Engl J Med 2006 10.45
4 Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998 5.71
5 Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 2005 3.81
6 Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 2003 3.44
7 Gammadelta T cells and the lymphoid stress-surveillance response. Immunity 2009 3.23
8 Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 2003 3.06
9 What is a natural killer cell? Nat Immunol 2002 2.11
10 Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group. Blood 2009 2.06
11 Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994 1.98
12 Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 1983 1.98
13 Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 2008 1.96
14 A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. Blood 2008 1.94
15 Human natural killer cells: origin, clonality, specificity, and receptors. Adv Immunol 1994 1.83
16 γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes. Blood 2015 1.56
17 HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders. Blood 2014 1.51
18 Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias. Immunol Rev 2008 1.47
19 Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med 1995 1.43
20 Acute graft-versus-host disease: a bench-to-bedside update. Blood 2014 1.23
21 Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant 2007 1.09
22 Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference. Clin Immunol 2009 1.04
23 Innate immunity: The unsung heroes. Nature 2003 0.95
24 Cord blood transplantation. Biol Blood Marrow Transplant 2006 0.94
25 Transplants across human leukocyte antigen barriers. Semin Hematol 2002 0.85
26 Stem cell escalation enables HLA-disparate haematopoietic transplants in leukaemia patients. Immunol Today 1999 0.80
27 Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies. Haematologica 2015 0.79
Next 100